Akebia Therapeutics Stock

Akebia Therapeutics Market capitalization 2024

Akebia Therapeutics Market capitalization

305.57 M USD

Ticker

AKBA

ISIN

US00972D1054

WKN

A1XF0S

In 2024, Akebia Therapeutics's market cap stood at 305.57 M USD, a 64.91% increase from the 185.3 M USD market cap in the previous year.

The Akebia Therapeutics Market capitalization history

YEARMarket Capitalization (undefined USD)
20230.19
20220.15
20210.54
20201.03
20190.64
20180.59
20170.59
20160.32
20150.26
20140.32
2013-
2012-
2011-

Akebia Therapeutics Aktienanalyse

What does Akebia Therapeutics do?

Akebia Therapeutics Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, USA. The company was founded in 2007 and focuses on the development and marketing of medications for the treatment of kidney diseases and other diseases. Akebia Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Akebia Therapeutics's Market Capitalization

Akebia Therapeutics's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Akebia Therapeutics's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Akebia Therapeutics's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Akebia Therapeutics’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Akebia Therapeutics stock

What is the current Akebia Therapeutics market capitalization?

The current market capitalization of Akebia Therapeutics is 305.57 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Akebia Therapeutics.

How has the market capitalization of Akebia Therapeutics developed in recent years?

The market capitalization of Akebia Therapeutics has increased/decreased by 64.91% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Akebia Therapeutics?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Akebia Therapeutics?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Akebia Therapeutics have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Akebia Therapeutics pay?

Over the past 12 months, Akebia Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Akebia Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Akebia Therapeutics?

The current dividend yield of Akebia Therapeutics is .

When does Akebia Therapeutics pay dividends?

Akebia Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Akebia Therapeutics?

Akebia Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Akebia Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Akebia Therapeutics located?

Akebia Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Akebia Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Akebia Therapeutics from 10/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/30/2024.

When did Akebia Therapeutics pay the last dividend?

The last dividend was paid out on 10/30/2024.

What was the dividend of Akebia Therapeutics in the year 2023?

In the year 2023, Akebia Therapeutics distributed 0 USD as dividends.

In which currency does Akebia Therapeutics pay out the dividend?

The dividends of Akebia Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Akebia Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Akebia Therapeutics

Our stock analysis for Akebia Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Akebia Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.